Hwee-Leong Tan1, Roxanne Y A Teo1, Nicholas L Syn2, Jin-Yao Teo1, Ser-Yee Lee1, Peng-Chung Cheow1, Pierce K H Chow1,3, Alexander Y F Chung1, London L P J Ooi1,3, Chung-Yip Chan1, Brian K P Goh4,5. 1. Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, 20 College Road, Academia Level 5, Singapore, 169856, Singapore. 2. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 3. Duke-National University of Singapore Medical School Singapore, Singapore, Singapore. 4. Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital, 20 College Road, Academia Level 5, Singapore, 169856, Singapore. bsgkp@hotmail.com. 5. Duke-National University of Singapore Medical School Singapore, Singapore, Singapore. bsgkp@hotmail.com.
Abstract
BACKGROUND: Pancreatic neuroendocrine neoplasms (PNENs) are increasingly prevalent with modern imaging, and surgical excision remains mainstay of treatment. This study aims to perform a propensity-score-matched (PSM) comparison of perioperative and oncologic outcomes following minimally invasive pancreatectomy (MIP) versus open pancreatectomy (OP) for PNEN. METHODS: A retrospective review was performed on patients who underwent curative-intent surgery for PNEN at Singapore General Hospital from 1997 to 2018. A 1:1 PSM was performed between MIP and OP, after which both groups were balanced for baseline variables. RESULTS: We studied 134 patients who underwent surgery (36 MIP and 98 OP) for PNEN. Propensity-score-matched comparison between 35 MIP and 35 OP patients revealed that the MIP group had a longer operating time (MD = 75.0, 95% CI 15.2 to 134.8, P = 0.015), lower intraoperative blood loss (MD = - 400.0, 95% CI - 630.5 to - 169.5, P = 0.001), shorter median postoperative stay (MD = - 1.0, 95% CI - 1.9 to - 0.1, P = 0.029) and shorter median time to diet (MD = - 1.0, 95% CI - 1.9 to - 0.1, P = 0.039). There were no differences between both groups for short-term adverse outcomes and oncologic clearance. Overall survival (HR = 0.84, 95% CI 0.28 to 2.51, P = 0.761) and disease-free survival (HR = 0.57, 95% CI 0.20 to 1.64, P = 0.296) were comparable. CONCLUSION: MIP is a safe and feasible approach for PNEN and is associated with a lower intraoperative blood loss, decreased postoperative stay and time to oral intake, at the expense of a longer operative time compared to OP.
BACKGROUND: Pancreatic neuroendocrine neoplasms (PNENs) are increasingly prevalent with modern imaging, and surgical excision remains mainstay of treatment. This study aims to perform a propensity-score-matched (PSM) comparison of perioperative and oncologic outcomes following minimally invasive pancreatectomy (MIP) versus open pancreatectomy (OP) for PNEN. METHODS: A retrospective review was performed on patients who underwent curative-intent surgery for PNEN at Singapore General Hospital from 1997 to 2018. A 1:1 PSM was performed between MIP and OP, after which both groups were balanced for baseline variables. RESULTS: We studied 134 patients who underwent surgery (36 MIP and 98 OP) for PNEN. Propensity-score-matched comparison between 35 MIP and 35 OP patients revealed that the MIP group had a longer operating time (MD = 75.0, 95% CI 15.2 to 134.8, P = 0.015), lower intraoperative blood loss (MD = - 400.0, 95% CI - 630.5 to - 169.5, P = 0.001), shorter median postoperative stay (MD = - 1.0, 95% CI - 1.9 to - 0.1, P = 0.029) and shorter median time to diet (MD = - 1.0, 95% CI - 1.9 to - 0.1, P = 0.039). There were no differences between both groups for short-term adverse outcomes and oncologic clearance. Overall survival (HR = 0.84, 95% CI 0.28 to 2.51, P = 0.761) and disease-free survival (HR = 0.57, 95% CI 0.20 to 1.64, P = 0.296) were comparable. CONCLUSION: MIP is a safe and feasible approach for PNEN and is associated with a lower intraoperative blood loss, decreased postoperative stay and time to oral intake, at the expense of a longer operative time compared to OP.
Authors: Stefano Partelli; Detlef K Bartsch; Jaume Capdevila; Jie Chen; Ulrich Knigge; Bruno Niederle; Els J M Nieveen van Dijkum; Ulrich-Frank Pape; Andreas Pascher; John Ramage; Nick Reed; Philippe Ruszniewski; Jean-Yves Scoazec; Christos Toumpanakis; Reza Kianmanesh; Massimo Falconi Journal: Neuroendocrinology Date: 2017-02-25 Impact factor: 4.914
Authors: Sang Hyup Han; In Woong Han; Jin Seok Heo; Seong Ho Choi; Dong Wook Choi; Sunjong Han; Yung Hun You Journal: Surg Endosc Date: 2017-06-29 Impact factor: 4.584
Authors: Horacio J Asbun; Alma L Moekotte; Frederique L Vissers; Filipe Kunzler; Federica Cipriani; Adnan Alseidi; Michael I D'Angelica; Alberto Balduzzi; Claudio Bassi; Bergthor Björnsson; Ugo Boggi; Mark P Callery; Marco Del Chiaro; Felipe J Coimbra; Claudius Conrad; Andrew Cook; Alessandro Coppola; Christos Dervenis; Safi Dokmak; Barish H Edil; Bjørn Edwin; Pier C Giulianotti; Ho-Seong Han; Paul D Hansen; Nicky van der Heijde; Jony van Hilst; Caitlin A Hester; Melissa E Hogg; Nicolas Jarufe; D Rohan Jeyarajah; Tobias Keck; Song Cheol Kim; Igor E Khatkov; Norihiro Kokudo; David A Kooby; Maarten Korrel; Francisco J de Leon; Nuria Lluis; Sanne Lof; Marcel A Machado; Nicolas Demartines; John B Martinie; Nipun B Merchant; I Quintus Molenaar; Cassadie Moravek; Yi-Ping Mou; Masafumi Nakamura; William H Nealon; Chinnusamy Palanivelu; Patrick Pessaux; Henry A Pitt; Patricio M Polanco; John N Primrose; Arab Rawashdeh; Dominic E Sanford; Palanisamy Senthilnathan; Shailesh V Shrikhande; John A Stauffer; Kyoichi Takaori; Mark S Talamonti; Chung N Tang; Charles M Vollmer; Go Wakabayashi; R Matthew Walsh; Shin-E Wang; Michael J Zinner; Christopher L Wolfgang; Amer H Zureikat; Maurice J Zwart; Kevin C Conlon; Michael L Kendrick; Herbert J Zeh; Mohammad Abu Hilal; Marc G Besselink Journal: Ann Surg Date: 2020-01 Impact factor: 12.969
Authors: Xu-Feng Zhang; Alexandra G Lopez-Aguiar; George Poultsides; Eleftherios Makris; Flavio Rocha; Zaheer Kanji; Sharon Weber; Ryan Fields; Bradley A Krasnick; Kamran Idrees; Paula M Smith; Cliff Cho; Carl R Schmidt; Shishir K Maithel; Timothy M Pawlik Journal: J Surg Oncol Date: 2019-04-18 Impact factor: 3.454
Authors: Gyulnara G Kasumova; Omidreza Tabatabaie; Mariam F Eskander; Abhishek Tadikonda; Sing Chau Ng; Jennifer F Tseng Journal: J Am Coll Surg Date: 2016-12-10 Impact factor: 6.113
Authors: Arvind Dasari; Chan Shen; Daniel Halperin; Bo Zhao; Shouhao Zhou; Ying Xu; Tina Shih; James C Yao Journal: JAMA Oncol Date: 2017-10-01 Impact factor: 31.777